The filoviruses Ebola (EBOV) virus and Marburg (MARV) virus are responsible for devastating hemorrhagic fever outbreaks. No vaccines or therapies are currently available against these agents. Because of the high morbidity and mortality associated with infection, these zoonotic viruses have been placed on the NIH Biodefense Category A list. A cellular receptor that binds to and mediates filovirus uptake has not been identified. Identification of such a receptor and elucidation of filoviral glycoprotein (GP)/receptor interactions will facilitate the development of antivirals and enhance knowledge of filoviral pathogenesis. This submission is designed to help fill this knowledge gap. We have identified that the surface protein TIM-1 serves as a cellular receptor for filoviruses on epithelial cells. These studies will elucidate the interactions between human and murine TIM-1 and filovirus glycoproteins that are required for binding and virus entry into endothelial cells. Additionally, our studies to date demonstrated that the expression of TIM-1 within the body is poorly understood. In tissue sections, we will identify cells that express TIM-1 hypothesizing that TIM-1 expression is common on many epithelia. Finally, using a tim-1 knock out mouse, we will determine the impact of Tim-1 on EBOV infection and pathogenesis in the mouse model. In total, these studies will pave the way for the development of future antivirals against these deadly viruses.
Outbreaks in Africa of the filoviruses, Ebola virus and Marburg virus, are sporadic and unpredictable with these deadly infections having mortality rates as high as 90% with no current vaccines or antiviral treatments available. Here, we identify that the cellular protein TIM-1 is a receptor for both Ebola and Marburg virus and seek to understand the molecular interactions between TIM-1 and filovirus glycoproteins that lead to virus infection. Further, studies will be performed to understand the role of TIM-1 in Ebola virus pathogenesis for a better understanding of cellular proteins that mediate filovirus binding and entry into cells that will facilitate the development of antiviral therapies potentially curbing transmission and infection.
|Anantpadma, Manu; Kouznetsova, Jennifer; Wang, Hang et al. (2016) Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors. Antimicrob Agents Chemother 60:4471-81|
|Rhein, Bethany A; Maury, Wendy J (2015) Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Microbiol Rep 2:115-124|
|Rhein, Bethany A; Powers, Linda S; Rogers, Kai et al. (2015) Interferon-Î³ Inhibits Ebola Virus Infection. PLoS Pathog 11:e1005263|
|Leung, Daisy W; Borek, Dominika; Luthra, Priya et al. (2015) An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Cell Rep 11:376-89|
|Lennemann, Nicholas J; Walkner, Madeline; Berkebile, Abigail R et al. (2015) The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2. J Infect Dis 212 Suppl 2:S204-9|
|Moller-Tank, Sven; Albritton, Lorraine M; Rennert, Paul D et al. (2014) Characterizing functional domains for TIM-mediated enveloped virus entry. J Virol 88:6702-13|
|Lennemann, Nicholas J; Rhein, Bethany A; Ndungo, Esther et al. (2014) Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. MBio 5:e00862-13|
|Moller-Tank, Sven; Maury, Wendy (2014) Phosphatidylserine receptors: enhancers of enveloped virus entry and infection. Virology 468-470:565-80|
|Kondratowicz, Andrew S; Hunt, Catherine L; Davey, Robert A et al. (2013) AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus. J Virol 87:746-55|
|Moller-Tank, Sven; Kondratowicz, Andrew S; Davey, Robert A et al. (2013) Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol 87:8327-41|
Showing the most recent 10 out of 14 publications